JP EQUITY · SINGLE-STOCK DEEP DIVE · 富士石油

후지석유(富士石油) — 정유 — 단일 정유소Fuji Oil Company (富士石油) — Refining — single refinery富士石油 — 石油精製 — 製油所1カ所

EDINET 有価証券報告書 FY2015~FY2024 를 이어 붙인 공통 재무 점검. 매출 4,255 → 8,402억엔, 영업이익률 -2.1% → -0.7%, ROIC -7.3% → -2.1%. 정유사는 이익의 큰 몫이 재고평가(유가 방향)에서 온다 — 그 몫을 먼저 걷어 내고 본다(②). 손익 엔진·현금·운전자본·자본 배분·장부 점검·밸류에이션, 그리고 이 주가가 이익(P/E)을 따라가는지 장부(P/B)에 묶였는지를 같은 틀로 잰다. 방향은 단정하지 않는다.A common financial check built by linking EDINET annual securities reports for FY2015~FY2024. Revenue 4,255 → 8,402 JPY 100mn, operating margin -2.1% → -0.7%, ROIC -7.3% → -2.1%. For refiners a large share of profit comes from inventory valuation (the direction of oil prices) — that share is stripped out first (②). The profit engine, cash, working capital, capital allocation, accounting checks and valuation — and whether this share price tracks earnings (P/E) or is anchored to book value (P/B) — are measured with the same frame. No view on direction is taken.EDINETの有価証券報告書FY2015~FY2024をつなぎ合わせた共通の財務点検。売上高4,255 → 8,402億円、 営業利益率-2.1% → -0.7%、ROIC -7.3% → -2.1%。 石油元売りは利益の大きな部分が在庫評価(原油価格の方向)から来る — その分をまず取り除いて見る(②)。 損益エンジン・現金・運転資本・資本配分・帳簿点検・バリュエーション、そしてこの株価が利益(P/E)に連動するのか簿価(P/B)に縛られているのかを同じ枠組みで測る。方向は断定しない。

FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 회계기준 Japan GAAP. 기말 주가·시가총액·P/B 는 그해 有報의 EPS × PER 로 역산한 가공값(적자 해는 PER 미기재로 빈칸). 분기보고서는 2024년 4월 폐지 — 그 뒤는 반기뿐이다(마지막 반기 2025 H1 · 2025-09-30).FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). Accounting standard: Japan GAAP. Year-end share prices, market cap and P/B are derived values back-calculated as EPS × P/E from that year’s annual securities report (loss years are blank because P/E is not reported). Quarterly securities reports were abolished in April 2024 — after that there are only half-year figures (last half 2025 H1 · 2025-09-30).FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). 会計基準日本基準。 期末株価・時価総額・P/Bはその年の有報のEPS × PERから逆算した加工値(赤字の年はPER記載なしのため空欄)。 四半期報告書は2024年4月に廃止 — それ以降は半期のみ(直近の半期2025 H1 · 2025-09-30)。
매출 FY2024Revenue FY2024売上高 FY20248,402억엔8,402 JPY 100mn8,402億円FY2015 4,255억엔FY2015 4,255 JPY 100mnFY2015 4,255億円
영업이익률Operating margin営業利益率-0.7%FY2015 -2.1%
ROIC(영업 투하자본)ROIC (operating invested capital)ROIC(営業投下資本)-2.1%고점 FY2016 11.8%Peak FY2016 11.8%ピーク FY2016 11.8%
안전마진Margin of safety安全余裕率-82.8%영업 레버리지 -1.21배Operating leverage -1.21x営業レバレッジ-1.21倍
누적 FCFCumulative FCF累計FCF-182억엔-182 JPY 100mn-182億円FY2015~FY2024
P/B (가공)P/B (derived)P/B(加工値)—배—x—倍범위 0.27~0.47Range 0.27~0.47範囲0.27~0.47
P/E—배—x—倍배당수익률 —%Dividend yield —%配当利回り—%
P/E 냐 P/B 냐P/E or P/BP/EかP/Bかβ 0.21장부에 묶임Anchored to book簿価に縛られる

① 손익 패널Income statement panel損益パネル — FY2015~FY2024

억엔 · 비율 = 매출 대비 % · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).JPY 100mn · ratios = % of revenue · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025).億円 · 比率 = 売上高比% · FY = 결산월이 1~3월이면 그 전해, 4~12월이면 그해(2026년 3월 결산 = FY2025 · 2025년 8월 결산 = FY2025). · Data as of 2025-03-31 · Created 2026-11-01
FY매출Revenue売上高매출총이익률Gross margin売上総利益率판관비율SG&A ratio販管費率연구개발/매출R&D/revenue研究開発費/売上高영업이익Operating profit営業利益영업이익률Operating margin営業利益率경상이익Ordinary profit経常利益특별손익Extraordinary items特別損益순이익Net profit純利益특별 제외 순이익Net profit ex. extraordinary items特別損益除く純利益ROE
20154,255-1.3%0.8% —%-88-2.1%-95 -0-94 -94-19.9%
20164,1955.4%0.9% —%1894.5%181 -2155 15628.2%
20174,2383.5%0.9% —%1122.6%86 -279 8112.0%
20185,4161.6%0.7% —%490.9%36 -329 314.1%
20194,624-5.3%0.9% —%-287-6.2%-288 4-291 -293-51.7%
20203,4463.3%1.3% —%712.1%83 -265 6714.6%
20214,8534.2%0.9% —%1553.2%161 7152 14627.1%
20228,5091.2%0.6% —%500.6%47 -436 395.3%
20237,2373.1%0.8% —%1622.2%187 -2155 15719.7%
20248,402-0.1%0.6% —%-56-0.7%-39 -18-58 -45-6.7%
반기Half半期매출Revenue売上高매출총이익률Gross margin売上総利益率판관비SG&A販管費영업이익Operating profit営業利益영업이익률Operating margin営業利益率경상이익Ordinary profit経常利益순이익Net profit純利益
2024 H14,272 — —-146 -3.4% -137-162
2024 H24,130 — —90 2.2% 98104
2025 H11,758 — —-183 -10.4% -182-182
매출은 FY2015 4,255억엔에서 FY2024 8,402억엔(연 7.8%), 영업이익률은 -2.1% → -0.7%. 특별 제외 순이익 = 순이익 − 특별손익 × (1 − 그해 실효세율). 2024-04 四半期報告書 폐지로 2024년 하반기부터는 반기만 있다 — 최근 반기 2025 H1 영업이익 -183억엔(전년 같은 반기 -146억엔).Revenue went from 4,255 JPY 100mn in FY2015 to 8,402 JPY 100mn in FY2024 (7.8% a year); operating margin -2.1% → -0.7%. Net profit ex. extraordinary items = net profit − extraordinary items × (1 − that year's effective tax rate). With quarterly securities reports abolished in April 2024, only half-year figures exist from the second half of 2024 — latest half 2025 H1: operating profit -183 JPY 100mn (same half a year earlier -146 JPY 100mn).売上高はFY2015の4,255億円からFY2024の8,402億円(年率7.8%)、営業利益率は-2.1% → -0.7%。 特別損益除く純利益 = 純利益 − 特別損益 ×(1 − その年の実効税率)。2024年4月の四半期報告書廃止により、2024年下期からは半期のみ — 直近の半期2025 H1の営業利益-183億円(前年同半期-146億円)。

② 재고평가 효과 — 이익 중 유가가 만든 몫Inventory valuation effect — the share of profit made by oil prices在庫評価影響 — 利益のうち原油価格がもたらした分

억엔JPY 100mn億円 · Data as of 2025-03-31 · Created 2026-11-01
FY기준 이익Profit measure基準利益보고 이익Reported profit報告利益재고평가 효과Inventory valuation effect在庫評価影響효과 제외 이익Profit ex. effect影響除く利益|효과| ÷ 보고 이익|Effect| ÷ reported profit|影響| ÷ 報告利益
2016営業利益Operating profit営業利益189 75113 40%
2017営業利益Operating profit営業利益112 4072 36%
2018営業利益Operating profit営業利益49 2425 49%
2019営業利益Operating profit営業利益-287 -204-83 71%
2020営業利益Operating profit営業利益71 87-16 123%
2021営業利益Operating profit営業利益155 187-32 120%
2022営業利益Operating profit営業利益50 743 14%
2023営業利益Operating profit営業利益162 9765 60%
2024営業利益Operating profit営業利益-56 -8731 156%
재고평가 효과 누계 226억엔 · 보고 이익 대비 |효과| 중앙값 60% · 가장 큰 해 FY2019 -204억엔. 재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. 손익 엔진·ROIC 는 보고 이익 그대로라 이 효과가 섞여 있다.Cumulative inventory valuation effect 226 JPY 100mn · median |effect| relative to reported profit 60% · largest year FY2019 -204 JPY 100mn. 재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. The profit engine and ROIC use reported profit as is, so this effect is mixed in.在庫評価影響の累計226億円 · 報告利益に対する|影響|の中央値60% · 最大の年FY2019 -204億円。재고평가 효과 + = 유가 상승기 원가 押し下げ(이익 증가), − = 하락기 押し上げ. 기준 이익은 회사가 MD&A·결산 설명에서 쓴 것 그대로. 損益エンジン・ROICは報告利益のままのため、この影響が混じっている。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 회사가 MD&A·결산 설명에 밝힌 재고평가 영향을 옮겼다 — 회사마다 기준 이익(営業利益·セグメント利益·経常利益)이 다르고, 영향을 밝히지 않은 해는 빠진다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Inventory valuation effects as disclosed by the company in its MD&A and results briefings — the profit measure differs by company (operating profit, segment profit, ordinary profit), and years in which the effect was not disclosed are omitted.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 会社がMD&A・決算説明で開示した在庫評価影響を転記した — 基準とする利益(営業利益・セグメント利益・経常利益)は会社ごとに異なり、影響を開示していない年は含まない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

③ 비용 구조 — 매출 1엔이 어디로 가나Cost structure — where each yen of revenue goesコスト構造 — 売上1円はどこへ行くか

매출 대비 %% of revenue売上高比% · Data as of 2025-03-31 · Created 2026-11-01
매출원가율 FY2015 101.3% → FY2024 100.1% · 판관비율 0.8% → 0.6% · 연구개발/매출 —% → —% · 감가상각/매출 1.8% → 0.9%. 판관비는 손익계산서 합계(판매비·일반관리비 구분 없음), 연구개발비는 주석의 총액(판관비 안 포함분), 감가상각은 현금흐름표 합계라 다른 선과 겹친다 — 더하면 안 된다.Cost-of-sales ratio FY2015 101.3% → FY2024 100.1% · SG&A ratio 0.8% → 0.6% · R&D/revenue —% → —% · depreciation/revenue 1.8% → 0.9%. SG&A is the income-statement total (no split between selling and G&A expenses); R&D is the total from the notes (including the part within SG&A) and depreciation is the cash-flow-statement total, so they overlap with the other lines — do not add them up.売上原価率FY2015 101.3% → FY2024 100.1% · 販管費率0.8% → 0.6% · 研究開発費/売上高—% → —% · 減価償却費/売上高1.8% → 0.9%。 販管費は損益計算書の合計(販売費・一般管理費の区分なし)、研究開発費は注記の総額(販管費に含まれる分を含む)、減価償却費はキャッシュ・フロー計算書の合計のため、他の線と重複する — 足し合わせてはならない。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 판관비 구분·연구개발비·감가상각은 원문 계정 그대로라 서로 겹친다(연구개발비는 판관비·제조원가 안에, 감가상각은 현금흐름표 합계) — 더하면 안 된다. 세로축은 로그 눈금.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: The SG&A breakdown, R&D and depreciation follow the original accounts and overlap (R&D sits inside SG&A and manufacturing cost; depreciation is the cash-flow-statement total) — do not add them up. The vertical axis is on a log scale.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 販管費の内訳・研究開発費・減価償却費は原文の勘定科目のままで互いに重複する(研究開発費は販管費・製造原価の中、減価償却費はキャッシュ・フロー計算書の合計)— 足し合わせてはならない。縦軸は対数目盛。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

④ 손익 엔진 — 고정비가 얼마나 무거워졌나Profit engine — how much heavier fixed costs have become損益エンジン — 固定費はどれだけ重くなったか

억엔 · % · 계정 분류(勘定科目法)JPY 100mn · % · account-classification method億円 · % · 勘定科目法 · Data as of 2025-03-31 · Created 2026-11-01
안전마진 — 매출이 몇 % 빠지면 영업적자인가Margin of safety — how far revenue can fall (%) before an operating loss安全余裕率 — 売上が何%減ると営業赤字か
FY2015-376.0%
FY2024-82.8%
손익분기 매출 20,256 → 15,356억엔Break-even revenue 20,256 → 15,356 JPY 100mn損益分岐点売上高20,256 → 15,356億円
고정비(판관비 + 감가상각)Fixed costs (SG&A + depreciation)固定費(販管費 + 減価償却費)
FY2015111억엔111 JPY 100mn111億円
FY2024123억엔123 JPY 100mn123億円
공헌이익률 0.5% → 0.8%Contribution margin 0.5% → 0.8%限界利益率0.5% → 0.8%
영업 레버리지 — 매출 1% 변화 → 영업이익 몇 %Operating leverage — % change in operating profit per 1% change in revenue営業レバレッジ — 売上1%の変化 → 営業利益は何%
FY2015-0.27배-0.27x-0.27倍
FY2024-1.21배-1.21x-1.21倍
공헌이익 ÷ 영업이익Contribution ÷ operating profit限界利益 ÷ 営業利益
변동비율 여유 — 원가율이 몇 %p 오르면 적자인가Variable-cost headroom — how many pp the cost ratio can rise before a loss変動費率の余裕 — 原価率が何%pt上がると赤字か
FY2024-0.7%p-0.7pp-0.7%pt
= 영업이익률. 원료가가 판가보다 이만큼 더 오르면 고정비를 못 덮는다.= operating margin. If raw-material prices rise this much more than selling prices, fixed costs are no longer covered.= 営業利益率。原料価格が販売価格よりこれだけ多く上がると、固定費を賄えない。
FY매출Revenue売上高변동비Variable costs変動費고정비Fixed costs固定費공헌이익률Contribution margin限界利益率손익분기 매출Break-even revenue損益分岐点売上高안전마진Margin of safety安全余裕率영업 레버리지Operating leverage営業レバレッジ
20154,2554,232111 0.5%20,256-376.0%-0.27
20164,1953,91492 6.7%1,37367.3%1.49
20174,2384,03294 4.9%1,93554.3%1.84
20185,4165,265103 2.8%3,67232.2%3.10
20194,6244,801109 -3.8%——%0.62
20203,4463,267108 5.2%2,07839.7%2.52
20214,8534,581117 5.6%2,08157.1%1.75
20228,5098,332126 2.1%6,08228.5%3.51
20237,2376,939136 4.1%3,30854.3%1.84
20248,4028,335123 0.8%15,356-82.8%-1.21
회귀로는 못 잰다Not measurable by regression回帰では測れない 분기 비용(매출 − 영업이익)을 매출에 회귀하면 기울기 0.99(±0.03, R² 0.97, 2016Q1~2023Q4 32분기) · 절편(분기 고정비) 3억엔. 비용이 매출과 거의 1:1 로 움직여(판가가 원료에 연동) 고정비가 통계적으로 잡히지 않는다 — 그래서 계정 분류로 나눴다.Regressing quarterly costs (revenue − operating profit) on revenue gives a slope of 0.99 (±0.03, R² 0.97, 2016Q1~2023Q4, 32 quarters) · intercept (quarterly fixed costs) 3 JPY 100mn. Costs move almost 1:1 with revenue (selling prices are linked to raw materials), so fixed costs cannot be identified statistically — hence the split by account.四半期コスト(売上高 − 営業利益)を売上高に回帰すると傾き0.99(±0.03、R² 0.97、2016Q1~2023Q4、32四半期)· 切片(四半期の固定費)3億円。 コストが売上高とほぼ1:1で動く(販売価格が原料に連動)ため、固定費が統計的に捉えられない — そこで勘定科目で分けた。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 고정비·변동비는 계정으로 나눈 근사이지 회사가 공시한 원가 구조가 아니다 — 매출원가 안 인건비는 변동으로, 판관비 안 운임은 고정으로 들어간다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Fixed and variable costs are an approximation split by account, not a cost structure disclosed by the company — labour costs within cost of sales count as variable and freight within SG&A as fixed.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 固定費・変動費は勘定科目で分けた近似であり、会社が開示した原価構造ではない — 売上原価中の人件費は変動費に、販管費中の運賃は固定費に入る。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑤ 발생액 — 순이익 vs 영업현금흐름Accruals — net profit vs operating cash flow発生高 — 純利益 vs 営業キャッシュ・フロー

억엔JPY 100mn億円 · Data as of 2025-03-31 · Created 2026-11-01
발생액/총자산 3년 평균Accruals/total assets, 3-year average発生高/総資産 3年平均-1.6%
순이익 > 영업현금흐름인 해Years with net profit > operating cash flow純利益 > 営業キャッシュ・フローの年6 / 10년6 / 10 years6 / 10年
누적 영업현금흐름Cumulative operating cash flow累計営業キャッシュ・フロー563억엔563 JPY 100mn563億円
누적 순이익Cumulative net profit累計純利益229억엔229 JPY 100mn229億円
발생액 = 순이익 − 영업현금흐름. 음수면 현금이 이익보다 많이 들어왔다(감가상각이 큰 장치산업의 정상 모습). 크게 양수로 돌면 이익의 질을 의심한다.Accruals = net profit − operating cash flow. A negative value means more cash came in than profit (normal for capital-intensive industries with heavy depreciation). A large swing to positive casts doubt on earnings quality.発生高 = 純利益 − 営業キャッシュ・フロー。マイナスなら利益より多くの現金が入った(減価償却の大きい装置産業では正常な姿)。大きくプラスに転じたら利益の質を疑う。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 연결 연간 값. 영업현금흐름엔 운전자본 변동이 들어 있어 원료 시차가 큰 해에 크게 흔들린다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Consolidated annual figures. Operating cash flow includes working-capital changes, so it swings widely in years with large raw-material time lags.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 連結の年次値。営業キャッシュ・フローには運転資本の増減が含まれるため、原料のタイムラグが大きい年は大きく振れる。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑥ CAPEX · FCF — 번 돈과 넣은 돈Capex · FCF — money earned and money investedCAPEX · FCF — 稼いだお金と投じたお金

억엔JPY 100mn億円 · Data as of 2025-03-31 · Created 2026-11-01
누적 설비투자 ÷ 누적 감가상각Cumulative capex ÷ cumulative depreciation累計設備投資 ÷ 累計減価償却費1.09배1.09x1.09倍
최근 3년 설비투자 ÷ 감가상각Capex ÷ depreciation, last 3 years直近3年の設備投資 ÷ 減価償却費0.47배0.47x0.47倍
누적 FCFCumulative FCF累計FCF-182억엔-182 JPY 100mn-182億円
FCF 적자 연도Years with negative FCFFCFマイナスの年2016 · 2017 · 2018 · 2019 · 2021 · 2022
FCF 수익률 FY2024FCF yield FY2024FCF利回り FY2024—%
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 설비투자는 유·무형자산 취득 현금만 — 리스로 들인 자산과 기업 인수는 빠진다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Capex covers only cash paid to acquire property, plant and equipment and intangible assets — leased assets and acquisitions are excluded.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 設備投資は有形・無形固定資産の取得による支出のみ — リースで取得した資産と企業買収は含まない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑦ 운전자본 — 매출채권 · 재고 · 매입채무 회전Working capital — receivables · inventory · payables turnover運転資本 — 売上債権・棚卸資産・仕入債務の回転

일 · 기말 잔액 기준Days · year-end balances日 · 期末残高ベース · Data as of 2025-03-31 · Created 2026-11-01
현금 전환 주기(CCC = DSO + DIO − DPO)는 FY2015 —일 → FY2024 —일 (매출채권 33 → 34일 · 재고 40 → 62일 · 매입채무 — → —일). 주기는 짧아졌다. 매출채권은 전자기록채권 포함. 재고는 매출원가 기준.The cash conversion cycle (CCC = DSO + DIO − DPO) went from — days in FY2015 to — days in FY2024 (receivables 33 → 34 days · inventory 40 → 62 days · payables — → — days). The cycle has shortened. Receivables include electronically recorded monetary claims. Inventory is measured against cost of sales.キャッシュ・コンバージョン・サイクル(CCC = DSO + DIO − DPO)はFY2015の—日 → FY2024の—日 (売上債権33 → 34日 · 棚卸資産40 → 62日 · 仕入債務— → —日)。 サイクルは短くなった。 売上債権は電子記録債権を含む。棚卸資産は売上原価ベース。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 잔액 기준이라 결산일 계절성이 섞인다. 매출채권은 전자기록채권을 포함(공시된 해)하고, 재고·매입채무는 매출원가 기준.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Based on year-end balances, so balance-sheet-date seasonality is mixed in. Receivables include electronically recorded monetary claims (in years they are disclosed); inventories and payables are measured against cost of sales.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末残高ベースのため決算日の季節性が混じる。売上債権は電子記録債権を含み(開示された年)、棚卸資産・仕入債務は売上原価ベース。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑧ ROIC · ROE · ROA — 자본에서 얼마를 버나ROIC · ROE · ROA — how much is earned on capitalROIC・ROE・ROA — 資本からどれだけ稼ぐか

% · Data as of 2025-03-31 · Created 2026-11-01
ROIC(세후 영업이익 ÷ 영업 투하자본)는 FY2015 -7.3% · 고점 FY2016 11.8% · FY2024 -2.1%. 영업 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유주식 포함) — 본업에 묶인 돈만 남긴다. ROE·ROA 는 기초·기말 평균 분모.ROIC (after-tax operating profit ÷ operating invested capital) was -7.3% in FY2015 · peak FY2016 11.8% · FY2024 -2.1%. Operating invested capital = equity + interest-bearing debt − cash and short-term securities − investment securities (including cross-shareholdings) — leaving only the money tied up in the core business. ROE and ROA use the average of opening and closing balances as the denominator.ROIC(税引後営業利益 ÷ 営業投下資本)はFY2015 -7.3% · ピークFY2016 11.8% · FY2024 -2.1%。 営業投下資本 = 自己資本 + 有利子負債 − 現金・短期有価証券 − 投資有価証券(政策保有株式を含む)— 本業に拘束されたお金だけを残す。ROE・ROAは期首・期末の平均を分母とする。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 영업 투하자본에서 투자유가증권(정책보유 포함)을 뺐다 · 세율은 그해 실효세율 · 기초·기말 평균 분모라 첫 해는 기말만.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Investment securities (including cross-shareholdings) are excluded from operating invested capital · the tax rate is that year's effective rate · denominators average opening and closing balances, so the first year uses the closing balance only.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 営業投下資本から投資有価証券(政策保有株式を含む)を除いた · 税率はその年の実効税率 · 分母は期首・期末の平均のため、初年度は期末のみ。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑨ 자본 배분 — FY2015~FY2024 누적, 돈은 어디로 갔나Capital allocation — cumulative FY2015~FY2024: where did the money go資本配分 — FY2015~FY2024累計、お金はどこへ行ったか

억엔 · 현금흐름표 누계JPY 100mn · cumulative cash-flow statement億円 · キャッシュ・フロー計算書の累計 · Data as of 2025-03-31 · Created 2026-11-01
영업현금흐름Operating cash flow営業キャッシュ・フロー563억엔563 JPY 100mn563億円
설비투자Capex設備投資744억엔744 JPY 100mn744億円
주주환원(배당 + 자사주)Shareholder returns (dividends + buybacks)株主還元(配当 + 自社株買い)57억엔57 JPY 100mn57億円
투자주식 매각 대금Proceeds from selling investment securities投資有価証券の売却収入166억엔166 JPY 100mn166億円
순현금 변화(기말 − 기초)Change in net cash (closing − opening)ネットキャッシュの増減(期末 − 期首)-338억엔-338 JPY 100mn-338億円
FCF -182억엔 vs 주주환원 57억엔 — 환원이 FCF 를 넘었다. 차액은 투자주식 매각과 순현금 감소로 메웠다. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF -182 JPY 100mn vs shareholder returns 57 JPY 100mn — returns exceeded FCF; the gap was covered by selling investment securities and drawing down net cash. 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.FCF -182億円 vs 株主還元57億円 — 還元がFCFを上回った。差額は投資有価証券の売却とネットキャッシュの減少で賄った。 누적은 첫 해 포함. 순현금 변화 = 마지막 해 − 첫 해 기말.
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 현금흐름표 누계 — 연결 범위 변경·환율 효과·기타 재무 항목은 따로 싣지 않았다.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Cumulative cash-flow-statement figures — changes in the scope of consolidation, FX effects and other financing items are not shown separately.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: キャッシュ・フロー計算書の累計 — 連結範囲の変更・為替の影響・その他の財務項目は個別に載せていない。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑩ 특별손익 — 본업 밖 이익이 얼마나 받치나Extraordinary items — how much non-core profit props up earnings特別損益 — 本業以外の利益がどれだけ支えているか

억엔JPY 100mn億円 · Data as of 2025-03-31 · Created 2026-11-01
FY특별이익Extraordinary gains特別利益투자주식 매각익Gains on sale of investment securities投資有価証券売却益특별손실Extraordinary losses特別損失감손Impairment減損특별손익 ÷ 세전이익Extraordinary items ÷ pre-tax profit特別損益 ÷ 税引前利益
20150.1—0.1 0.00.1%
20160.1—1.7 0.0-0.9%
20170.00.02.1 0.5-2.4%
20180.20.22.8 0.0-7.7%
201911.70.17.9 —-1.4%
20200.90.82.4 1.3-1.9%
20217.4—0.7 0.04.0%
20220.40.44.3 0.0-9.1%
20230.5—2.5 2.3-1.1%
20240.1—18.4 0.032.0%
FY2015~FY2024 투자주식 매각익 누계 1억엔 = 누적 순이익 229억엔의 0.6%(세전 기준이라 상한). 최근 3년 특별손익 ÷ 세전이익 평균 7.3%.Cumulative gains on sale of investment securities FY2015~FY2024: 1 JPY 100mn = 0.6% of cumulative net profit of 229 JPY 100mn (pre-tax basis, so an upper bound). Average extraordinary items ÷ pre-tax profit over the last 3 years: 7.3%.FY2015~FY2024の投資有価証券売却益の累計1億円 = 累計純利益229億円の0.6%(税引前ベースのため上限)。直近3年の特別損益 ÷ 税引前利益の平均7.3%。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 특별손익은 일본기준 손익계산서 구분 그대로 · 특별 제외 순이익은 그해 실효세율로 세후 환산한 근사.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Extraordinary items follow the Japan GAAP income-statement classification · net profit excluding extraordinary items is an approximation converted to after-tax at that year's effective tax rate.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 特別損益は日本基準の損益計算書の区分のまま · 特別損益除く純利益はその年の実効税率で税引後に換算した近似。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑪ 장부 점검 게이지 — 5개 플래그Accounting check gauges — 5 flags帳簿点検ゲージ — 5個のフラグ

빨강 0 · 주황 0 · 최근 연도 기준Red 0 · amber 0 · latest year赤0 · 橙0 · 直近年度ベース · Data as of 2025-03-31 · Created 2026-11-01
이익−현금 괴리(발생액/총자산, 3년 평균)Profit–cash gap (accruals/total assets, 3-year average)利益と現金の乖離(発生高/総資産、3年平均)
-1.6%-1.6%-1.6% · 기준 5%· threshold 5%· 基準5%
순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).순이익이 영업현금흐름보다 크게 앞서면 이익의 질을 의심한다(Sloan).
매출채권 증가 − 매출 증가(최근 연도)Receivables growth − revenue growth (latest year)売上債権の増加 − 売上高の増加(直近年度)
-23.0%-23.0%-23.0% · 기준 10%· threshold 10%· 基準10%
채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.채권이 매출보다 빨리 늘면 밀어내기·회수 지연 신호.
재고 증가 − 매출 증가(최근 연도)Inventory growth − revenue growth (latest year)棚卸資産の増加 − 売上高の増加(直近年度)
-22.9%-22.9%-22.9% · 기준 10%· threshold 10%· 基準10%
재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).재고가 매출보다 빨리 늘면 수요 둔화를 재고로 받고 있을 수 있다(원가 이연).
특별손익 ÷ 세전이익(3년 평균)Extraordinary items ÷ pre-tax profit (3-year average)特別損益 ÷ 税引前利益(3年平均)
7.3%7.3%7.3% · 기준 20%· threshold 20%· 基準20%
투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.투자주식 매각익 등 본업 밖 이익이 세전이익을 받치고 있는지.
설비투자 ÷ 감가상각(3년) vs 매출 연성장Capex ÷ depreciation (3 years) vs annual revenue growth設備投資 ÷ 減価償却費(3年)vs 売上高の年成長率
0.47배0.47x0.47倍 · 기준 2.0배· threshold 2.0x· 基準2.0倍
상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 20.1%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 20.1%.상각의 2배 넘게 투자하는데 매출 3년 연성장이 3% 미만이면 투자 회수가 의문. 매출 3년 연성장 20.1%.

⑫ 밸류에이션 — P/B · P/E · EV/EBITDAValuation — P/B · P/E · EV/EBITDAバリュエーション — P/B・P/E・EV/EBITDA

배 · 기말 주가는 가공값x · year-end prices are derived values倍 · 期末株価は加工値 · Data as of 2025-03-31 · Created 2026-11-01
FY시가총액(억엔)Market cap (JPY 100mn)時価総額(億円)P/BP/EEV/EBITDA배당수익률Dividend yield配当利回りFCF 수익률FCF yieldFCF利回り순현금 ÷ 시총Net cash ÷ market capネットキャッシュ ÷ 時価総額투자유가증권 ÷ 시총Investment securities ÷ market cap投資有価証券 ÷ 時価総額
2015——— ——%—% —%—%
20162950.471.9 5.92.09%-89.8% -384.9%58.1%
20173260.474.1 8.31.89%-12.8% -336.0%52.1%
20181940.276.7 11.93.97%-60.0% -601.2%83.9%
2019——— ——%—% —%—%
20201760.372.7 8.34.37%108.5% -539.6%105.6%
20211980.311.3 7.13.90%-226.7% -711.4%106.9%
20222040.295.7 13.33.78%-37.2% -728.8%128.3%
20233720.432.4 7.73.11%6.8% -394.9%81.8%
2024——— ——%—% —%—%
시가총액 = 기말 주가(가공) × (발행주식 − 자기주식). EV = 시가총액 + 이자부채(리스 포함) − 현금·단기유가증권. 투자유가증권(정책보유 포함)은 EV 에서 빼지 않았다 — 표의 마지막 열이 그 크기다.Market cap = year-end price (derived) × (shares issued − treasury shares). EV = market cap + interest-bearing debt (including leases) − cash and short-term securities. Investment securities (including cross-shareholdings) are not deducted from EV — the last column of the table shows their size.時価総額 = 期末株価(加工値)×(発行済株式数 − 自己株式数)。EV = 時価総額 + 有利子負債(リースを含む)− 現金・短期有価証券。投資有価証券(政策保有株式を含む)はEVから差し引いていない — 表の最終列がその大きさだ。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 기말 주가는 그해 有報의 EPS × PER 로 역산한 가공값 — 시장 주가 원천을 쓰지 않았다. 적자 해는 PER 미기재로 빈칸.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Year-end share prices are derived values back-calculated as EPS × P/E from that year's annual securities report — no market price source is used. Loss years are blank because P/E is not reported.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 期末株価はその年の有報のEPS × PERから逆算した加工値 — 市場の株価データは使っていない。赤字の年はPER記載なしのため空欄。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑬ P/E 냐 P/B 냐 — 이 주가는 무엇을 따라가나P/E or P/B — what does this share price track?P/EかP/Bか — この株価は何に連動するか

有報 5년 표 FY2012~FY20245-year tables in the annual securities reports FY2012~FY2024有報の5年表 FY2012~FY2024 · Data as of 2025-03-31 · Created 2026-11-01
이 종목 · 그해 이익 기준This stock · same-year earningsこの銘柄 · その年の利益ベース
β 0.21
log(P/B) 를 log(ROE) 에 회귀한 기울기(±0.11, 7년). 1 이면 ROE 가 변해도 P/E 가 그대로(이익을 따라감), 0 이면 P/B 가 그대로(장부에 묶임). → P/B 에 묶여 있다.Slope from regressing log(P/B) on log(ROE) (±0.11, 7 years). 1 means P/E stays put as ROE changes (tracks earnings); 0 means P/B stays put (anchored to book). → anchored to P/B.log(P/B)をlog(ROE)に回帰した傾き(±0.11、7年)。1ならROEが変わってもP/Eは不変(利益に連動)、0ならP/Bが不変(簿価に縛られる)。→ P/Bに縛られている。
이 종목 · 3년 평균 이익 기준This stock · 3-year average earningsこの銘柄 · 3年平均利益ベース
β —
일시 이익은 주가에 안 실린다(일회성이면 P/E 가 반대로 움직인다). 3년 평균 EPS 로 바꿔 다시 잰 값(±—, 년).One-off profits are not priced in (if a profit is one-off, P/E moves the other way). Re-measured with 3-year average EPS (±—, years).一時的な利益は株価に織り込まれない(一過性ならP/Eが逆に動く)。3年平均EPSに替えて測り直した値(±—、年)。
P/B 변화 분해 FY2016→FY2023Decomposition of P/B change FY2016→FY2023P/B変化の分解 FY2016→FY2023
-8%
log(P/B) 변화 = log(ROE) -32% + log(P/E) +23%. P/B 범위 0.27~0.47배 · 표준편차(log) P/E 0.59 vs P/B 0.23.Change in log(P/B) = log(ROE) -32% + log(P/E) +23%. P/B range 0.27~0.47x · standard deviation (log) P/E 0.59 vs P/B 0.23.log(P/B)の変化 = log(ROE) -32% + log(P/E) +23%。P/Bの範囲0.27~0.47倍 · 標準偏差(log)P/E 0.59 vs P/B 0.23。
일본 시장 표본 369사 · 회사 안 시계열Japan market sample, 369 companies · within-company time series日本市場の標本369社 · 企業内の時系列
β 0.15
같은 회귀를 369사(3443개 회사-연도)에 — 3년 평균 이익 기준 β 0.18. 회사별 β 중앙값 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.The same regression across 369 companies (3443 company-years) — β on 3-year average earnings 0.18. Median company β 0.22. 그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.同じ回帰を369社(3443の企業・年度)に — 3年平均利益ベースのβ 0.18。企業別βの中央値0.22。그해 이익으로도, 3년 평균 이익으로도 β 가 0 쪽 — 일본 주가는 평균적으로 이익보다 장부(P/B)에 묶여 있다.
점 하나 = 한 해(그해 ROE = EPS ÷ BPS, P/B = PER × EPS ÷ BPS — 둘 다 같은 有報 5년 표의 같은 주식 기준이라 분할·병합에 무관). 적자 해는 PER 이 비어 빠진다(6년).Each dot = one year (ROE that year = EPS ÷ BPS, P/B = P/E × EPS ÷ BPS — both on the same share basis from the same 5-year table in the annual securities report, so unaffected by splits and consolidations). Loss years have no P/E and are excluded (6 years).点1つ = 1年(その年のROE = EPS ÷ BPS、P/B = PER × EPS ÷ BPS — どちらも同じ有報5年表の同じ株式ベースのため、分割・併合の影響を受けない)。赤字の年はPERが空欄のため除外(6年)。
出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 한 회사의 연간 관측이라 표본이 작다(표준오차를 함께 적었다) · 적자 해는 빠진다 · 평탄화 이익은 그해 포함 직전 연도들의 EPS/BPS 평균.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: Annual observations of a single company, so the sample is small (standard errors are shown alongside) · loss years are excluded · smoothed earnings are the average EPS/BPS of the preceding years including that year.
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

出典:EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)、PDL1.0(https://www.digital.go.jp/resources/open_data/public_data_license_v1.0)
EDINET閲覧(提出)サイト(https://disclosure2.edinet-fsa.go.jp/)の富士石油株式会社提出書類をもとにAdrenalin Baby作成(編集・加工)
Limitations: 1社の年次観測のため標本が小さい(標準誤差を併記した)· 赤字の年は除外 · 平準化利益はその年を含む直近数年のEPS/BPSの平均。
Processing: derived figures calculated by Adrenalin Baby; the source agencies are not responsible for them.
DISCLOSURE

Disclosure: Adrenalin Baby is the personal research activity of an individual. It is not, and is not affiliated with, any investment adviser, financial adviser, broker-dealer or financial institution. The information reflects the author's views, opinions and analyses as of the creation date shown and is provided for informational purposes only; it does not constitute an offer to sell or a solicitation of an offer to buy any security or investment product. Derived figures are calculated by Adrenalin Baby from third-party sources believed to be reliable but not independently verified; Adrenalin Baby makes no representation or warranty of any kind, express or implied, as to their accuracy, consistency, completeness or timeliness, and figures and calculations may contain errors. Any forward-looking statements involve risks and uncertainties, and actual results may differ materially. Nothing herein is legal, tax, accounting or investment advice; recipients should consult their own advisers. Past performance is not a guarantee or indicator of future results; every investment carries the risk of loss. Data sources, terms and attribution: www.adrenalinbaby.com/Adrenalinbaby_DataUsage

⑭ 측정 한계Measurement limitations測定の限界

1고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.고정비·변동비는 계정 분류(매출원가 − 감가상각 = 변동, 판관비 + 감가상각 = 고정) 근사다. 매출원가 안 인건비(반고정)는 변동으로, 판관비 안 운임(변동)은 고정으로 들어간다. 감가상각은 현금흐름표 합계라 판관비 몫이 겹친다.
22024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.2024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.2024-04 四半期報告書 폐지 → 2024년 하반기부터는 반기만 있다. 4분기 편중·분기 회귀는 그 전 기간만.
3기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.기말 주가는 有報 5년 표의 PER × EPS 로 역산한 가공값이다. 적자 해(PER 미기재)는 주가·P/B 가 비고, 그해는 P/E·P/B 판정에서 빠진다.
4ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).ROIC 의 투하자본 = 자기자본 + 이자부채 − 현금·단기유가증권 − 투자유가증권(정책보유 포함). 세율은 그해 실효세율(0~60% 밖이면 30.6%).

같이 볼 페이지Related pages併せて見るページ